William O Cooper, MD, MPH discusses malpractice management and utilizing patient complaint data to improve the consistency and quality of overall care.
A report from the American Cancer Society Cancer Action Network estimated the total costs to patients associated with cancer diagnoses and treatment, based on their type of insurance.
Kerin B Adelson, MD, spoke about how palliative services can improve patient care and reduce wasteful medical expenditures in oncology. 
Jennifer Singleterry, MA, speaks about the wide-ranging implications for cancer care and the associated costs in relation to health care and insurance reform.
The future of clinical pathways largely depends on alternative payment models such as the Oncology Care Model sponsored by CMS, according to Edward Stepanski, PhD.
Journal of Clinical Pathways spoke with Tudor Borza, MD, clinical lecturer in urology at University of Michigan Medical School, Ann Arbor, MI.
Journal of Clinical Pathways spoke with David A Hughes, BSN, about how the Seattle Cancer Care Alliance integrates the patient viewpoint and a collective understanding of value into clinical pathway practice.
Journal of Clinical Pathways spoke with Alex W Bastian, MBA, strategic advisor, ASCO Value In Cancer Task Force, about how his role in the Task Force has impacted his views concerning value-based care, health care reform, and clinical pathways.
The role of targeted therapies and clinical pathways in shaping future treatment practices for marginal zone lymphoma.
Journal of Clinical Pathways spoke with Dana A Telem, MD, MPH, to better understand the role clinical pathways can play in standardizing bariatric surgery practices.